The Phase IIa trial is a randomized, placebo-controlled study evaluating the safety, tolerability, and preliminary clinical signals of ONP-002 in patients presenting with acute concussion and mild ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results